专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US5763474A Substituted N-arylmethylamino derivatives of cyclobutene-3,4-diones 失效
标题翻译：取代的环丁烯-3,4-二酮的N-芳基甲基氨基衍生物
公开(公告)号：US5763474A
公开(公告)日：1998-06-09
申请号：US889164
申请日：1997-07-07
申请人： David R. Herbst , Madelene M. Antane , Geraldine R. McFarlane , Eric G. Gundersen , Bradford H. Hirth , Dominick A. Quagliato , Russell F. Graceffa , John A. Butera
发明人： David R. Herbst , Madelene M. Antane , Geraldine R. McFarlane , Eric G. Gundersen , Bradford H. Hirth , Dominick A. Quagliato , Russell F. Graceffa , John A. Butera
IPC分类号： C07C225/20 , C07C233/41 , C07C255/58 , C07C271/24 , A61K31/135 , A61K31/165 , C07C235/82
CPC分类号： C07C225/20 , C07C233/41 , C07C255/58 , C07C271/24 , C07C2101/04 , C07C2101/08
摘要： The compounds of the formula: ##STR1## wherein R.sub.1 is straight chain alkyl, branched chain alkyl cycloalkyl, hydroxyalkyl, fluoroalkyl or polyfluoroalkyl; R.sub.2 and R.sub.3 are, independently, hydrogen or an acyl substituent selected from the group consisting of formyl, alkanoyl, alkenoyl, alkoxycarbonyl, alkylsulfonyl, aroyl, arylalkenoyl, arylsulfonyl, arylalkanoyl or arylalkylsulfonyl; A is a substituted phenyl group of the following formula: ##STR2## wherein R.sub.4 and R.sub.5 are, independently, cyano, nitro, amino, alkyl, perfluoroalkyl, fluoroalkyl, alkoxy, perfluoroalkoxy, fluoroalkoxy, amino, alkylamino, dialkylamino, sulfamyl, alkylsulfonamido, arylsulfonamido, carbamoyl, alkylcarbamoyl, dialkylcarbamoyl, alkylcarboxamido, arylcarboxamido, alkylsulfonyl, perfluoroalkylsulfonyl, arylsulfonyl, chloro, bromo, fluoro, iodo, 1-imidazolyl, carboxyl or hydrogen, with the proviso that R.sub.4 and R.sub.5 cannot both be hydrogen; or a pharmaceutically acceptable salt thereof, relaxes smooth muscles.
摘要翻译：下式的化合物：其中R 1是直链烷基，支链烷基环烷基，羟基烷基，氟烷基或多氟烷基; R2和R3独立地为氢或选自甲酰基，烷酰基，烯酰基，烷氧基羰基，烷基磺酰基，芳酰基，芳基烯酰基，芳基磺酰基，芳基烷酰基或芳基烷基磺酰基的酰基取代基。 A是下式的取代苯基：其中R 4和R 5独立地是氰基，硝基，氨基，烷基，全氟烷基，氟烷基，烷氧基，全氟烷氧基，氟烷氧基，氨基，烷基氨基，二烷基氨基，氨基磺酰基，烷基亚磺酰氨基，芳基亚磺酰氨基，氨基甲酰基，烷基氨基甲酰基，二烷基氨基甲酰基，烷基酰胺基，芳基羧酰氨基，烷基磺酰基，全氟烷基磺酰基，芳基磺酰基，氯，溴，氟，碘，1-咪唑基，羧基或氢，条件是R4和R5不能都是氢; 或其药学上可接受的盐，使平滑肌松弛。

2. 发明授权

US5872139A Heterocyclymethylamino derivatives of cyclobutene-3,4-diones 失效
标题翻译：环丁烯-3,4-二酮的杂环甲基氨基衍生物
公开(公告)号：US5872139A
公开(公告)日：1999-02-16
申请号：US873132
申请日：1997-06-10
申请人： David R. Herbst , John A. Butera , Russell F. Graceffa
发明人： David R. Herbst , John A. Butera , Russell F. Graceffa
IPC分类号： C07D213/38 , C07D307/81 , C07D307/82 , A61K31/34 , A61K31/44 , C07D213/50
CPC分类号： C07D307/82 , C07D213/38 , C07D307/81
摘要： The compounds of the formula: ##STR1## wherein R.sub.1 and R.sub.2 are, independently, hydrogen, straight chain alkyl, branched chain alkyl, cycloalkyl, bicycloalkyl or aralkyl, wherein the aromatic moiety of the aralkyl group may be optionally substituted with one to three straight chain alkyl, halogen, nitro, cyano, alkoxy, alkoxycarbonyl, trifluoromethyl or trifluoromethoxy groups; R.sub.3 is hydrogen, formyl, alkanoyl, alkenoyl, alkylsulfonyl, aroyl, arylalkenoyl, arylsulfonyl, arylalkanoyl or arylalkylsulfonyl; A is selected from the group consisting of: ##STR2## wherein n is 0 or 1; R.sub.4, R.sub.5 and R.sub.6 are, independently, cyano, nitro, amino, alkyl, perfluoroalkyl, alkoxy, perfluoroalkoxy, alkylamino, dialkylamino, sulfamyl, alkylsulfonamido, arylsulfonamido, alkylcarboxamido, arylcarboxamido, alkanoyl, alkylsulfonyl, perfluoroalkylsulfonyl, arylsulfonyl, chloro, bromo, fluoro, iodo, 1-imidazolyl, carboxyl or hydrogen; or a pharmaceutically acceptable salt thereof, relax smooth muscles.
摘要翻译：下式的化合物：其中R 1和R 2独立地是氢，直链烷基，支链烷基，环烷基，双环烷基或芳烷基，其中芳烷基的芳族部分可以任选地被一个三个直链烷基，卤素，硝基，氰基，烷氧基，烷氧基羰基，三氟甲基或三氟甲氧基; R 3是氢，甲酰基，烷酰基，烯酰基，烷基磺酰基，芳酰基，芳基烯酰基，芳基磺酰基，芳基烷酰基或芳基烷基磺酰基; A选自由以下组成的组：其中n为0或1; R 4，R 5和R 6独立地是氰基，硝基，氨基，烷基，全氟烷基，烷氧基，全氟烷氧基，烷基氨基，二烷基氨基，氨基磺酰基，烷基磺酰氨基，芳基磺酰氨基，烷基羧酰氨基，芳基羧酰氨基，烷酰基，烷基磺酰基，全氟烷基磺酰基，芳基磺酰基，氯，溴，氟，碘，1-咪唑基，羧基或氢; 或其药学上可接受的盐，使平滑肌松弛。

3. 发明授权

US5780505A Substituted N-arylmethylamino derivatives of cyclobutene-3, 4-diones 失效
标题翻译：取代的环丁基-3,4-二酮的N-芳基甲基氨基衍生物
公开(公告)号：US5780505A
公开(公告)日：1998-07-14
申请号：US889166
申请日：1997-07-07
申请人： Madelene M. Antane , David R. Herbst , Geraldine R. McFarlane , Eric G. Gundersen , Bradford H. Hirth , Dominick A. Quagliato , Russell F. Graceffa , John A. Butera
发明人： Madelene M. Antane , David R. Herbst , Geraldine R. McFarlane , Eric G. Gundersen , Bradford H. Hirth , Dominick A. Quagliato , Russell F. Graceffa , John A. Butera
IPC分类号： C07C225/20 , C07C233/41 , C07C255/58 , C07C271/24 , A61K31/275
CPC分类号： C07C255/58 , C07C225/20 , C07C233/41 , C07C271/24 , C07C2101/04 , C07C2101/08
摘要： The compounds of the formula: ##STR1## wherein R.sub.1 is straight chain alkyl, branched chain alkyl, cycloalkyl, hydroxyalkyl, fluoroalkyl or polyfluoroalkyl; R.sub.7 and R.sub.8 are, independently, hydrogen or an acyl substituent selected from the group consisting of formyl, alkanoyl, alkenoyl, alkoxycarbonyl, alkylsulfonyl, aroyl, arylalkenoyl, arylsulfonyl, arylalkanoyl or arylalkylsulfonyl; A is a phenyl group with either two or three substituents of the following formula: ##STR2## wherein the positions of substitution are R.sub.2,R.sub.3 -, R.sub.2,R.sub.4 -, R.sub.2,R.sub.5 -, R.sub.2,R.sub.6 -, R.sub.3,R.sub.4 -, R.sub.3,R.sub.5 -, and R.sub.2,R.sub.4,R.sub.6 - and R.sub.2 is methyl, ethyl, fluoro, chloro, methoxy or trifluoromethyl; R.sub.3 is methyl, ethyl, fluoro, chloro, methoxy or trifluoromethyl; R.sub.4 is methyl, fluoro, bromo, methoxy or cyano; R.sub.5 is methyl, fluoro, chloro, methoxy, cyano or trifluoromethyl; R.sub.6 is methyl, fluoro, chloro, or methoxy; or a pharmaceutically acceptable salt thereof, relax smooth muscles.
摘要翻译：下式的化合物：其中R 1是直链烷基，支链烷基，环烷基，羟基烷基，氟烷基或多氟烷基; R 7和R 8独立地是氢或选自甲酰基，烷酰基，烯酰基，烷氧基羰基，烷基磺酰基，芳酰基，芳基烯酰基，芳基磺酰基，芳基烷酰基或芳基烷基磺酰基的酰基取代基。 A是具有下式的两个或三个取代基的苯基：其中取代的位置是R2，R3-，R2，R4-，R2，R5-，R2，R6-，R3，R4-， R 3，R 5和R 2，R 4，R 6和R 2是甲基，乙基，氟，氯，甲氧基或三氟甲基; R3是甲基，乙基，氟，氯，甲氧基或三氟甲基; R4是甲基，氟，溴，甲氧基或氰基; R5是甲基，氟，氯，甲氧基，氰基或三氟甲基; R6是甲基，氟，氯或甲氧基; 或其药学上可接受的盐，使平滑肌松弛。

4. 发明授权

US07008636B2 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia 失效
标题翻译：用于治疗胰岛素抵抗和高血糖症的2,3,5-取代联苯
公开(公告)号：US07008636B2
公开(公告)日：2006-03-07
申请号：US10843026
申请日：2004-05-11
申请人： John A. Butera , Craig E. Caufield , Russell F. Graceffa , Alexander Greenfield , Eric G. Gundersen , Lisa Marie Havran , Alan H. Katz , Joseph R. Lennox , Scott C. Mayer , Robert E. McDevitt
发明人： John A. Butera , Craig E. Caufield , Russell F. Graceffa , Alexander Greenfield , Eric G. Gundersen , Lisa Marie Havran , Alan H. Katz , Joseph R. Lennox , Scott C. Mayer , Robert E. McDevitt
IPC分类号： A61K31/343 , A61K31/19 , C07D307/78 , C07C53/134
CPC分类号： C07D213/40 , C07C17/16 , C07C45/68 , C07C45/71 , C07C47/575 , C07C205/35 , C07C205/37 , C07C309/77 , C07D209/08 , C07D233/54 , C07D263/58 , C07D307/58 , C07D307/80 , C07D307/81 , C07D317/54 , C07D333/74 , C07D413/12 , C07F9/4006 , C07C22/04
摘要： This invention provides compounds of Formula I having the structure or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia.
摘要翻译：本发明提供了具有结构或其可药用盐的式I化合物，其可用于治疗与胰岛素抵抗或高血糖相关的代谢紊乱。

5. 发明授权

US06451827B2 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia 失效
标题翻译：用于治疗胰岛素抵抗和高血糖症的2,3,5-取代联苯
公开(公告)号：US06451827B2
公开(公告)日：2002-09-17
申请号：US09771469
申请日：2001-01-26
申请人： John A. Butera , Craig E. Caufield , Russell F. Graceffa , Alexander Greenfield , Eric G. Gundersen , Lisa Marie Havran , Alan H. Katz , Joseph R. Lennox , Scott C. Mayer , Robert E. McDevitt
发明人： John A. Butera , Craig E. Caufield , Russell F. Graceffa , Alexander Greenfield , Eric G. Gundersen , Lisa Marie Havran , Alan H. Katz , Joseph R. Lennox , Scott C. Mayer , Robert E. McDevitt
IPC分类号： A61K3144
CPC分类号： C07D213/40 , C07C17/16 , C07C45/68 , C07C45/71 , C07C47/575 , C07C205/35 , C07C205/37 , C07C309/77 , C07D209/08 , C07D233/54 , C07D263/58 , C07D307/58 , C07D307/80 , C07D307/81 , C07D317/54 , C07D333/74 , C07D413/12 , C07F9/4006 , C07C22/04
摘要： This invention provides compounds of Formula I having the structure wherein: B, C, D, and R1 are as defined hereinbefore in the specification, or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia.
摘要翻译：本发明提供具有结构的式I化合物，其中B，C，D和R 1如本说明书中所定义，或其药学上可接受的盐，其可用于治疗与胰岛素抵抗或高血糖相关的代谢紊乱。

6. 发明授权

US06765021B2 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia 失效
标题翻译：用于治疗胰岛素抵抗和高血糖症的2,3,5-取代联苯
公开(公告)号：US06765021B2
公开(公告)日：2004-07-20
申请号：US10215438
申请日：2002-08-09
申请人： John A. Butera , Craig E. Caufield , Russell F. Graceffa , Alexander Greenfield , Eric G. Gundersen , Lisa Marie Havran , Alan H. Katz , Joseph R. Lennox , Scott C. Mayer , Robert E. McDevitt
发明人： John A. Butera , Craig E. Caufield , Russell F. Graceffa , Alexander Greenfield , Eric G. Gundersen , Lisa Marie Havran , Alan H. Katz , Joseph R. Lennox , Scott C. Mayer , Robert E. McDevitt
IPC分类号： A61K3117
CPC分类号： C07F9/4006 , C07B2200/07 , C07C17/16 , C07C45/68 , C07C45/71 , C07C47/575 , C07C205/35 , C07C205/37 , C07C225/20 , C07C233/43 , C07C235/46 , C07C235/48 , C07C235/52 , C07C237/30 , C07C255/54 , C07C271/12 , C07C271/16 , C07C271/28 , C07C271/30 , C07C309/77 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2601/14 , C07D209/08 , C07D213/40 , C07D233/54 , C07D263/58 , C07D295/088 , C07D295/13 , C07D307/58 , C07D307/80 , C07D307/81 , C07D317/54 , C07D333/74 , C07D413/12 , C07C22/04
摘要： This invention provides compounds of formula I having the structure wherein: B, D, C, and R1 as defined herein.
摘要翻译：本发明提供具有本文定义的B，D，C和R 1结构的式I化合物。

7. 发明授权

US06214877B1 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia 失效
标题翻译：用于治疗胰岛素抵抗和高血糖症的2,3,5-取代联苯
公开(公告)号：US06214877B1
公开(公告)日：2001-04-10
申请号：US09307850
申请日：1999-05-10
申请人： John A. Butera , Craig E. Caufield , Russell F. Graceffa , Alexander Greenfield , Eric G. Gundersen , Lisa Marie Havran , Alan H. Katz , Joseph R. Lennox , Scott C. Mayer , Robert E. McDevitt
发明人： John A. Butera , Craig E. Caufield , Russell F. Graceffa , Alexander Greenfield , Eric G. Gundersen , Lisa Marie Havran , Alan H. Katz , Joseph R. Lennox , Scott C. Mayer , Robert E. McDevitt
IPC分类号： A61K31166
CPC分类号： C07F9/4006 , C07B2200/07 , C07C17/16 , C07C45/68 , C07C45/71 , C07C47/575 , C07C205/35 , C07C205/37 , C07C225/20 , C07C233/43 , C07C235/46 , C07C235/48 , C07C235/52 , C07C237/30 , C07C255/54 , C07C271/12 , C07C271/16 , C07C271/28 , C07C271/30 , C07C309/77 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2601/14 , C07D209/08 , C07D213/40 , C07D233/54 , C07D263/58 , C07D295/088 , C07D295/13 , C07D307/58 , C07D307/80 , C07D307/81 , C07D317/54 , C07D333/74 , C07D413/12 , C07C22/04
摘要： This invention provides compounds of Formula I having the structure wherein: B, C, D, and R1 are as defined hereinbefore in the specification, or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia.
摘要翻译：本发明提供具有结构的式I化合物，其中B，C，D和R 1如本说明书中所定义，或其药学上可接受的盐，其可用于治疗与胰岛素抵抗或高血糖相关的代谢紊乱。

8. 发明授权

US5846999A Substituted N-arylmethylamino derivatives of cyclobutene-3,4-diones 失效
标题翻译：取代的环丁烯-3,4-二酮的N-芳基甲基氨基衍生物
公开(公告)号：US5846999A
公开(公告)日：1998-12-08
申请号：US889165
申请日：1997-07-07
申请人： Madelene M. Antane , Bradford H. Hirth , Russell F. Graceffa , John A. Butera
发明人： Madelene M. Antane , Bradford H. Hirth , Russell F. Graceffa , John A. Butera
IPC分类号： C07C225/20 , C07C233/41 , C07C255/58 , C07C271/24 , A01N37/34
CPC分类号： C07C233/41 , C07C225/20 , C07C255/58 , C07C271/24 , C07C2101/04 , C07C2101/08
摘要： The compounds of the formula: ##STR1## wherein R.sub.1 is straight chain alkyl, branched chain alkyl, cycloalkyl, hydroxyalkyl, fluoroalkyl or polyfluoroalkyl; R.sub.2 and R.sub.3 are, independently, hydrogen or an acyl substituent selected from the group consisting of formyl, alkanoyl, alkenoyl, alkoxycarbonyl, alkylsulfonyl, aroyl, arylalkenoyl, arylsulfonyl, arylalkanoyl or arylalkylsulfonyl; or a pharmaceutically acceptable salt thereof, relaxes smooth muscles.
摘要翻译：下式的化合物：其中R 1是直链烷基，支链烷基，环烷基，羟基烷基，氟烷基或多氟烷基; R2和R3独立地为氢或选自甲酰基，烷酰基，烯酰基，烷氧基羰基，烷基磺酰基，芳酰基，芳基烯酰基，芳基磺酰基，芳基烷酰基或芳基烷基磺酰基的酰基取代基。或其药学上可接受的盐，使平滑肌松弛。

9. 发明授权

US07601856B2 Benzofurans as potassium ion channel modulators 失效
标题翻译：苯并呋喃作为钾离子通道调节剂
公开(公告)号：US07601856B2
公开(公告)日：2009-10-13
申请号：US11828457
申请日：2007-07-26
申请人： Gregory S. Welmaker , Matthew A. Wilson , Geraldine McFarlane , Joan E. Sabalski , John A. Butera , Eugene J. Trybulski , David R. Herbst
发明人： Gregory S. Welmaker , Matthew A. Wilson , Geraldine McFarlane , Joan E. Sabalski , John A. Butera , Eugene J. Trybulski , David R. Herbst
IPC分类号： C07D307/90
CPC分类号： C07D307/91 , C07D307/93 , C07D405/12 , C07D407/12 , C07D409/12 , C07D491/113
摘要： The present invention is directed to compounds of Formula I: that are potassium channel modulators and pharmaceutical compositions thereof. The present invention is further directed to methods of treatment using the compounds and pharmaceutical compositions of the invention. The present invention is still further directed to synthetic processes for producing the compounds of the invention.
摘要翻译：本发明涉及式I化合物：其是钾通道调节剂及其药物组合物。本发明还涉及使用本发明的化合物和药物组合物的治疗方法。本发明还涉及用于制备本发明化合物的合成方法。

10. 发明授权

US07879825B2 Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and methods of use thereof 失效
标题翻译： [2-（8,9-二氧代-2,6-二氮杂双环[5.2.0]壬-1（7） - 烯-2-基）烷基]膦酸的衍生物及其使用方法
公开(公告)号：US07879825B2
公开(公告)日：2011-02-01
申请号：US11757006
申请日：2007-06-01
申请人： Reinhardt B. Baudy , John A. Butera
发明人： Reinhardt B. Baudy , John A. Butera
IPC分类号： A61P25/00 , A61K31/675 , C07D223/00
CPC分类号： C07F9/645
摘要： Compounds of formula (I) or pharmaceutically acceptable salts thereof are provided where at least one of R2 or R3 is not hydrogen. The compounds of the present invention are N-methyl-D-aspartate (NMDA) receptor antagonists and are useful in treating a variety of conditions present in a mammal that benefit from inhibiting the NMDA receptor.
摘要翻译：提供式（I）化合物或其药学上可接受的盐，其中R 2或R 3中的至少一个不是氢。本发明的化合物是N-甲基-D-天冬氨酸（NMDA）受体拮抗剂，可用于治疗受益于抑制NMDA受体的哺乳动物中存在的各种病症。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式